KERYX BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 492515901. A total of 3 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $690,000 | +67.1% | 104,200 | +17.9% | 0.00% | 0.0% |
| Q1 2016 | $413,000 | -40.5% | 88,400 | -35.7% | 0.00% | 0.0% |
| Q4 2015 | $694,000 | +31.4% | 137,500 | -8.4% | 0.00% | 0.0% |
| Q3 2015 | $528,000 | -46.3% | 150,100 | +52.2% | 0.00% | 0.0% |
| Q2 2015 | $984,000 | +20.0% | 98,600 | +53.1% | 0.00% | 0.0% |
| Q1 2015 | $820,000 | -11.5% | 64,400 | -1.7% | 0.00% | 0.0% |
| Q4 2014 | $927,000 | +21.7% | 65,500 | +18.2% | 0.00% | 0.0% |
| Q3 2014 | $762,000 | +174.1% | 55,400 | +206.1% | 0.00% | – |
| Q2 2014 | $278,000 | -67.1% | 18,100 | -63.5% | 0.00% | -100.0% |
| Q1 2014 | $845,000 | +50.1% | 49,600 | +14.0% | 0.00% | 0.0% |
| Q4 2013 | $563,000 | -21.7% | 43,500 | -38.9% | 0.00% | 0.0% |
| Q3 2013 | $719,000 | +240.8% | 71,200 | +152.5% | 0.00% | – |
| Q2 2013 | $211,000 | – | 28,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 421,800 | $3,151,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 914 | $683,000 | 0.05% |
| Citadel Advisors | 28,200 | $211,000 | 0.00% |